Dry powder formulations comprising ascorbic acid derivates

Details for Australian Patent Application No. 2008325290 (hide)

Owner AstraZeneca AB

Inventors Trofast, Jan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008325290

PCT Pub. Number WO2009/061273

Priority 61/073,443 18.06.08 US; 60/986,026 07.11.07 US

Filing date 6 November 2008

Wipo publication date 14 May 2009

Acceptance publication date 8 December 2011

International Classifications

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/061273 Priority application(s): WO2009/061273

8 December 2011 Application Accepted

  Published as AU-B-2008325290

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008325291-Casted in cemented carbide components

2008325288-Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase